LJUBLJANA, Dec 16 (Reuters) - Slovenia's largest
pharmaceutical company Krka KRKG.LJ KRK.WA said on Tuesday
the recent significant depreciation of the Russian rouble was
likely to dent its earnings this year.
"The fall in the value of the Russian rouble has a negative
impact on the value of Krka group sales in the Russian
Federation and creates negative currency differences, which has
a negative impact on Krka's profit," Krka said in a statement
but gave no figures or estimates.
Krka, which sells about a quarter of its output to Russia,
said in November it expected group next profit this year to be
level with last year, when it reached 172.8 million euros.
ID:nL6N0SW41T
Shares of Krka, Slovenia's largest listed company, closed
1.74 percent lower at 56.6 euros on Tuesday, before the profit
warning was released, while the blue-chip SBI index .SBITOP
lost 1.19 percent.
(Reporting By Marja Novak; Editing by Zoran Radosavljevic and
Keith Weir)
((Marja.Novak@thomsonreuters.com; +386-8-205-6369; Reuters
Messaging: marja.novak.thomsonreuters.com@reuters.net))
Keywords: KRKA PROFIT/